Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Growth 2023-2029

Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Growth 2023-2029

Cardio Vascular Diseases or CVD is the world’s leading cause of death in men and women and these deaths are due to heart failure, congenital heart disease, peripheral vascular disease, cardiomyopathy, coronary heart disease and stroke. Cardio vascular monitoring devices help in identifying electrical and pressure waveforms of the cardiovascular system for the treatment and measurement of cardio vascular diseases. Nowadays, new emerging non-invasive cardiovascular monitoring technologies are playing very important role in treatment therapies of cardio vascular diseases. This long term non-invasive cardiovascular monitoring has important prognostic applications and provides accurate information for cardiovascular treatment and diagnosis. Cardio vascular diagnosis tests include cardiac catheterization, blood tests, cardiac magnetic resonance imaging (MRI), electrocardiogram, cardiac computerized tomography (CT) scan and echocardiogram.

LPI (LP Information)' newest research report, the “Cardiovascular Disease Monitoring and Diagnostic Devices Industry Forecast” looks at past sales and reviews total world Cardiovascular Disease Monitoring and Diagnostic Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Disease Monitoring and Diagnostic Devices sales for 2023 through 2029. With Cardiovascular Disease Monitoring and Diagnostic Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Disease Monitoring and Diagnostic Devices industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Disease Monitoring and Diagnostic Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Disease Monitoring and Diagnostic Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Disease Monitoring and Diagnostic Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Disease Monitoring and Diagnostic Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Disease Monitoring and Diagnostic Devices.

The global Cardiovascular Disease Monitoring and Diagnostic Devices market size is projected to grow from US$ 2298.4 million in 2022 to US$ 3352.2 million in 2029; it is expected to grow at a CAGR of 3352.2 from 2023 to 2029.

With largest market share of around 38%, North America cardiovascular monitoring and diagnostic devices market is growing rapidly and it is expected to grow at CAGR of around 5.6% in the coming years. Europe is second largest market followed by Asia Pacific region for cardiovascular monitoring and diagnostic devices market. Europe is predicted to grow at healthy growth rate in forecast period with emerging advanced technologies in monitoring and diagnosis of cardiovascular diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Monitoring and Diagnostic Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
ECG Systems
Event Monitors
Holter Monitors
Implantable Loop Recorders
ECG Management Systems

Segmentation by application
Heart Disease
Coronary Heart Disease

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Bioanalytical Systems，Inc
Ge Healthcare
Philips Healthcare
Mortara Instrument, Inc
Spacelabs Healthcare Inc.
Schiller AG
Hill-Rom
Mindray Medical International Limited
Compumed Inc.
Cardionet Inc.
Gehealthcare

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Disease Monitoring and Diagnostic Devices market?

What factors are driving Cardiovascular Disease Monitoring and Diagnostic Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Disease Monitoring and Diagnostic Devices market opportunities vary by end market size?

How does Cardiovascular Disease Monitoring and Diagnostic Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.